Response to: 'Use of tanezumab for patients with hip and knee osteoarthritis with reference to a randomised clinical trial by Berenbaum and colleagues' by Riddle and Perera.
Francis BerenbaumFrancisco Javier BlancoAli GuermaziKenji MikiTakaharu YamabeLars ViktrupRod JunorWilliam CareyMark T BrownChristine R WestKenneth M VerburgPublished in: Annals of the rheumatic diseases (2020)